JMP Securities Maintains Wix.com(WIX.US) With Buy Rating, Maintains Target Price $180
KeyBanc Initiates Wix.com(WIX.US) With Hold Rating
Piper Sandler Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $20
Monday Com Price Target Announced at $250.00/Share by Baird
Monday.Com Analyst Ratings
Jefferies Remains a Buy on Pagaya Technologies Ltd (PGY)
Cellebrite DI's Strategic Expansion Into Federal Cybersecurity Market Prompts Buy Rating
Lake Street Sticks to Its Buy Rating for Cellebrite DI (CLBT)
Analysts Offer Insights on Technology Companies: Palantir Technologies (PLTR), Cellebrite DI (CLBT) and Array Technologies (ARRY)
Cellebrite DI (CLBT) Receives a Buy From Craig-Hallum
Nova Analyst Ratings
Monday.Com Analyst Ratings
Piper Sandler Maintains Overweight on Monday.Com, Maintains $270 Price Target
Piper Sandler Remains a Buy on Monday.com (MNDY)
Teva Pharmaceutical Indus Analyst Ratings
Argus Upgrades Teva to Buy, Cites Recent Drug Approvals
Monday.Com Analyst Ratings
Monday.Com Analyst Ratings
Teva Pharmaceutical Indus Analyst Ratings
Monday.Com Analyst Ratings